A Chinese drug-maker with military ties has sent an experimental Ebola drug to Africa for use by Chinese aid workers and is planning clinical trials there to combat a deadly outbreak of the disease, executives at the firm told Reuters on Thursday.
Sihuan Pharmaceutical Holdings Group Ltd has supplied several thousand doses of its drug JK-05 to the region, Chief Operating Officer Jia Zhongxin said. More doses could be sent if needed, Jia said. Sihuan, part-owned by Morgan Stanley, is hoping to get the drug fast-tracked for civilian use in China. It has signed an agreement with the Academy of Military Medical Sciences (AMMS), a research unit, to seek approval for its use in China and push it to market.
